Last Posted: Sep 23, 2017
- Precision Medicine Initiative begins enrolling participants in cohort
S Slabodkin, Health Data Management,Sep 2017 - Precision Medicine Is Our Best Hope In The Fight Against Cancer
Medical Futurist Newsletter - Precision Public Health and Precision Medicine: Two Peas in a Pod
MJ Khoury, CDC Blog Post 2015 - Editorial: Personalized Medicine: A Positional Point of View about Precision Medicine and Clarity for Ethics of Public Health.
Fineschi Vittorio et al. Current pharmaceutical biotechnology 2017 18(3) 192-193 - Genetic Test, Risk Prediction, and Counseling.
Wang Maggie Haitian et al. Advances in experimental medicine and biology 2017 100521-46 - Integrating genomics into population-based cancer surveillance in the era of precision medicine
MJ Khoury and L Penberthy, CDC Blog, Sep 19, 2017 - MicroRNA-21 as a prognostic biomarker in patients with pancreatic cancer - A systematic review and meta-analysis.
Negoi Ionut et al. American journal of surgery 2017 Sep 214(3) 515-524 - Newborn Screening in the Era of Precision Medicine.
Yang Lan et al. Advances in experimental medicine and biology 2017 100547-61 - Somatic Mutation Analysis of Human Cancers: Challenges in Clinical Practice.
Tsongalis Gregory J et al. Journal of clinical pharmacology 2017 Oct 57 Suppl 10S60-S66 - Clinical application of a cancer genomic profiling assay to guide precision medicine decisions.
Eifert Cheryl et al. Personalized medicine 2017 Jul 14(4) 309-325 - Functional precision cancer medicine-moving beyond pure genomics.
Letai Anthony et al. Nature medicine 2017 Sep 23(9) 1028-1035 - Implementing an Oncology Precision Medicine Clinic in a Large Community Health System
MJ Thompson et al. AJMC, August 2017 - Role of pharmacogenomics in antiepileptic drug therapy: current status and future perspectives.
Gambardella Antonio et al. Current pharmaceutical design 2017 Sep - NIH's massive health study is off to a slow start
J Kaiser, Science Sep 7, 2017 - Advances in the molecular genetics of gliomas - implications for classification and therapy.
Reifenberger Guido et al. Nature reviews. Clinical oncology 2017 Jul 14(7) 434-452 - Economic Considerations in the Use of Novel Targeted Therapies for Lung Cancer: Review of Current Literature.
Albaba Hamzeh et al. PharmacoEconomics 2017 Aug
No hay comentarios:
Publicar un comentario